Singapore markets closed

Nexien BioPharma, Inc. (NXEN)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.01690.0000 (0.00%)
As of 09:30AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Cash flows from operating activities
Net income
-246.182
-361.902
-626.357
-1,860
-2,672
-
Stock-based compensation
-
-
0
348.953
52.137
1,898
Change in working capital
21.909
2.888
13.9
7.385
35.548
-
Other working capital
-72.54
-81.751
-75.143
-90.745
-147.57
-
Other non-cash items
151.733
277.263
427.05
1,413
2,436
-
Net cash provided by operating activities
-72.54
-81.751
-75.143
-90.745
-147.57
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-
-30
Acquisitions, net
-
-
-
-
-
0
Net cash used for investing activities
0
0
0
0
0
-
Cash flows from financing activities
Common stock issued
-
-
-
-
-
0
Other financing activities
-
-
25
20
-
-
Net cash used provided by (used for) financing activities
28.4
0
174
98
12
-
Net change in cash
-44.14
-81.751
98.857
7.255
-135.57
-
Cash at beginning of period
54.207
116.898
18.041
10.786
146.356
-
Cash at end of period
10.067
35.147
116.898
18.041
10.786
-
Free cash flow
Operating cash flow
-72.54
-81.751
-75.143
-90.745
-147.57
-
Capital expenditure
-
-
-
-
-
-30
Free cash flow
-72.54
-81.751
-75.143
-90.745
-147.57
-